42 participants
A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-15
- Start Date:
- 2021-03-12
- Completion:
- 2023-05-08
Conditions
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
Interventions
- DRUG